Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Silver Point Capital Opposes John Paulson’s Proposal

The fight between the Lehman Brothers’ creditors continues. Two months ago John Paulson had to disclose that he paid as little as 9 cents on the dollar for Lehman’s debt. Now Paulson tries to turn the table and make dozens of banks and hedge funds disclose their transactions in Lehman’s bonds. Citigroup, TPG Capital and Edward Mule’s Silver Point Capital oppose Paulson’s proposal. Paulson’s proposal is “nothing more than a litigation tactic designed to attempt to intimidate parties in interest into abandoning any efforts to oppose,” they said in a court filing.

PAULSON & CO

We don’t really care who wins the argument. Distressed investing isn’t an easy task and hedge funds work and fight hard to generate returns. These returns don’t really have much correlation with the market, yet journalists and investors compare these hedge funds’ returns to the S&P 500 index.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...